MENU
+Compare
OCGN
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$0.68
Change
-$0.02 (-2.86%)
Capitalization
197.87M

OCGN Ocugen Forecast, Technical & Fundamental Analysis

a company, which engages in the development and commercialization of therapies for eye diseases

Industry Biotechnology
OCGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for OCGN with price predictions
Feb 21, 2025

OCGN in upward trend: price expected to rise as it breaks its lower Bollinger Band on February 11, 2025

OCGN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 36 cases where OCGN's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 75 cases where OCGN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for OCGN just turned positive on February 14, 2025. Looking at past instances where OCGN's MACD turned positive, the stock continued to rise in of 58 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where OCGN advanced for three days, in of 213 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on February 19, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on OCGN as a result. In of 102 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OCGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for OCGN entered a downward trend on February 18, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.871) is normal, around the industry mean (12.496). P/E Ratio (0.000) is within average values for comparable stocks, (84.451). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.603). OCGN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (38.023) is also within normal values, averaging (251.218).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. OCGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OCGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
OCGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

OCGN is expected to report earnings to rise 4.55% to -5 cents per share on March 28

Ocugen OCGN Stock Earnings Reports
Q4'24
Est.
$-0.06
Q3'24
Est.
$-0.06
Q2'24
Beat
by $0.01
Q1'24
Beat
by $0.02
Q4'23
Est.
$-0.03
The last earnings report on November 08 showed earnings per share of -5 cents, beating the estimate of -5 cents. With 2.52M shares outstanding, the current market capitalization sits at 197.87M.
A.I. Advisor
published General Information

General Information

a company, which engages in the development and commercialization of therapies for eye diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
11 Great Valley Parkway
Phone
+1 484 328-4701
Employees
84
Web
https://www.ocugen.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VCFVX11.46N/A
N/A
VALIC Company I International Value
GEQYX60.91N/A
N/A
GuideStone Funds Equity Index Instl
PZIMX12.04N/A
N/A
Pzena Mid Cap Value Instl
JACJX19.35N/A
N/A
JHancock Mid Cap Growth A
SROIX12.77-0.18
-1.39%
Calamos Antetokounmpo Sustainable Eqs I

OCGN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, OCGN has been loosely correlated with RAIN. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if OCGN jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCGN
1D Price
Change %
OCGN100%
-2.88%
RAIN - OCGN
53%
Loosely correlated
-0.75%
ARRY - OCGN
47%
Loosely correlated
-4.49%
AXON - OCGN
46%
Loosely correlated
-5.28%
AKBA - OCGN
37%
Loosely correlated
-5.76%
GLUE - OCGN
35%
Loosely correlated
-6.18%
More